NEW YORK, April 13 (GenomeWeb News) - Agilent Technologies and Partners HealthCare System said today that they have signed a one-year agreement for Agilent to provide microarray and gene expression products to Massachusetts General Hospital and Brigham and Women's Hospital.
Under the terms of the agreement, Agilent will supply the Partners HealthCare Center for Genetics and Genomics (HPCGG) with gene expression instrumentation, including a microarray scanner and a bioanalyzer.
The agreement also determines pricing for Partners HealthCare's hospitals to purchase analytical tools and instruments from Agilent's Life Sciences and Chemical Analysis group, including liquid and gas chromatographs, mass spectrometers, microarrays, microfluidic devices, software, columns, reagents, and other supplies.
Partners HealthCare is the parent organization for MGH and BWH. The HPCGG provides research services to those hospitals as well as McLean Hospital, Newton-Wellesley Hospital, North Shore Medical Center, Partners Community HealthCare, Dana-Farber/Partners CancerCare, and Harvard Clinical Research Institute.